These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32945346)

  • 1. Anti‑EGFR monoclonal antibody 134‑mG2a exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Hosono H; Takei J; Ohishi T; Sano M; Asano T; Sayama Y; Nakamura T; Yanaka M; Kawada M; Harada H; Kaneko MK; Kato Y
    Int J Mol Med; 2020 Oct; 46(4):1443-1452. PubMed ID: 32945346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma.
    Takei J; Kaneko MK; Ohishi T; Hosono H; Nakamura T; Yanaka M; Sano M; Asano T; Sayama Y; Kawada M; Harada H; Kato Y
    Oncol Rep; 2020 Nov; 44(5):1949-1960. PubMed ID: 33000243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti‑EpCAM monoclonal antibody exerts antitumor activity against oral squamous cell carcinomas.
    Kaneko MK; Ohishi T; Takei J; Sano M; Nakamura T; Hosono H; Yanaka M; Asano T; Sayama Y; Harada H; Kawada M; Kato Y
    Oncol Rep; 2020 Dec; 44(6):2517-2526. PubMed ID: 33125138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG
    Tateyama N; Nanamiya R; Ohishi T; Takei J; Nakamura T; Yanaka M; Hosono H; Saito M; Asano T; Tanaka T; Sano M; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):177-183. PubMed ID: 34424762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas.
    Ishikawa K; Suzuki H; Ohishi T; Li G; Tanaka T; Kawada M; Ohkoshi A; Kaneko MK; Katori Y; Kato Y
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of EMab-134, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Detecting Squamous Cell Carcinoma Cells of the Oral Cavity.
    Itai S; Yamada S; Kaneko MK; Chang YW; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):272-281. PubMed ID: 29090976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
    Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
    Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Exerted Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor.
    Tanaka T; Ohishi T; Saito M; Suzuki H; Kaneko MK; Kawada M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Jun; 41(3):142-149. PubMed ID: 35666554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.
    Tanaka T; Ohishi T; Asano T; Takei J; Nanamiya R; Hosono H; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defucosylated anti-PD-L1 monoclonal antibody 13-mG
    Takei J; Ohishi T; Kaneko MK; Harada H; Kawada M; Kato Y
    Biochem Biophys Rep; 2020 Dec; 24():100801. PubMed ID: 32923698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity.
    Takei J; Kaneko MK; Ohishi T; Kawada M; Harada H; Kato Y
    Oncol Lett; 2020 Apr; 19(4):2809-2816. PubMed ID: 32218834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Activities in Mouse Xenograft Models of Canine Mammary Gland Tumor by Defucosylated Mouse-Dog Chimeric Anti-Epidermal Growth Factor Receptor Antibody (E134Bf).
    Li G; Suzuki H; Takei J; Asano T; Sano M; Tanaka T; Harada H; Mizuno T; Ohishi T; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2022 Apr; 41(2):53-58. PubMed ID: 35471048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of panitumumab alone or with chemotherapy in non-small cell lung carcinoma cell lines expressing mutant epidermal growth factor receptor.
    Freeman DJ; Bush T; Ogbagabriel S; Belmontes B; Juan T; Plewa C; Van G; Johnson C; Radinsky R
    Mol Cancer Ther; 2009 Jun; 8(6):1536-46. PubMed ID: 19509246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry.
    Itai S; Kaneko MK; Fujii Y; Yamada S; Nakamura T; Yanaka M; Saidoh N; Handa S; Chang YW; Suzuki H; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):214-219. PubMed ID: 28891752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
    Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
    Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors.
    Li G; Ohishi T; Kaneko MK; Takei J; Mizuno T; Kawada M; Saito M; Suzuki H; Kato Y
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors.
    Suzuki H; Ohishi T; Asano T; Tanaka T; Saito M; Mizuno T; Yoshikawa T; Kawada M; Kaneko MK; Kato Y
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Metastatic Activity of an Anti-EGFR Monoclonal Antibody against Metastatic Colorectal Cancer with
    Ohishi T; Kato Y; Kaneko MK; Ohba SI; Inoue H; Harakawa A; Kawada M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
    Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
    Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.